Renaissance Technologies’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-409,284
| Closed | -$178K | – | 4534 |
|
2022
Q4 | $178K | Buy |
409,284
+47,284
| +13% | +$20.6K | ﹤0.01% | 3462 |
|
2022
Q3 | $101K | Sell |
362,000
-98,394
| -21% | -$27.5K | ﹤0.01% | 3597 |
|
2022
Q2 | $166K | Sell |
460,394
-106,759
| -19% | -$38.5K | ﹤0.01% | 3715 |
|
2022
Q1 | $380K | Sell |
567,153
-86,547
| -13% | -$58K | ﹤0.01% | 3360 |
|
2021
Q4 | $843K | Sell |
653,700
-158,903
| -20% | -$205K | ﹤0.01% | 2772 |
|
2021
Q3 | $1.76M | Buy |
+812,603
| New | +$1.76M | ﹤0.01% | 2187 |
|
2021
Q2 | – | Sell |
-481,707
| Closed | -$1.26M | – | 3889 |
|
2021
Q1 | $1.26M | Buy |
+481,707
| New | +$1.26M | ﹤0.01% | 2505 |
|
2020
Q4 | – | Sell |
-440,923
| Closed | -$2.04M | – | 3822 |
|
2020
Q3 | $2.04M | Sell |
440,923
-245,000
| -36% | -$1.13M | ﹤0.01% | 2121 |
|
2020
Q2 | $1.93M | Buy |
685,923
+217,800
| +47% | +$614K | ﹤0.01% | 2202 |
|
2020
Q1 | $1.14M | Buy |
468,123
+147,700
| +46% | +$360K | ﹤0.01% | 2362 |
|
2019
Q4 | $1.64M | Buy |
320,423
+42,400
| +15% | +$217K | ﹤0.01% | 2413 |
|
2019
Q3 | $1.8M | Sell |
278,023
-51,800
| -16% | -$335K | ﹤0.01% | 2337 |
|
2019
Q2 | $2.06M | Buy |
329,823
+7,435
| +2% | +$46.3K | ﹤0.01% | 2311 |
|
2019
Q1 | $3.43M | Buy |
322,388
+24,250
| +8% | +$258K | ﹤0.01% | 2037 |
|
2018
Q4 | $2.38M | Buy |
298,138
+36,675
| +14% | +$292K | ﹤0.01% | 2139 |
|
2018
Q3 | $5.06M | Buy |
261,463
+98,513
| +60% | +$1.91M | 0.01% | 1788 |
|
2018
Q2 | $2.95M | Sell |
162,950
-78,775
| -33% | -$1.42M | ﹤0.01% | 2070 |
|
2018
Q1 | $2.57M | Buy |
241,725
+215,175
| +810% | +$2.29M | ﹤0.01% | 2200 |
|
2017
Q4 | $1.12M | Buy |
26,550
+2,237
| +9% | +$94.3K | ﹤0.01% | 2620 |
|
2017
Q3 | $1.34M | Buy |
+24,313
| New | +$1.34M | ﹤0.01% | 2463 |
|
2016
Q4 | – | Sell |
-8,725
| Closed | -$977K | – | 3534 |
|
2016
Q3 | $977K | Buy |
+8,725
| New | +$977K | ﹤0.01% | 2579 |
|